ADIAL PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Adial Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Adial Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $610K, a 93.3% decline year-over-year.
  • Adial Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.13M, a 54.7% decline from 2022.
  • Adial Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9.13M, a 33.1% decline from 2021.
  • Adial Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $13.6M, a 143% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.13M -$4.99M -54.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $9.13M -$4.52M -33.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $13.6M +$8.04M +143% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $5.61M -$3.64M -39.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $9.25M +$2.9M +45.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 $6.35M +$5.96M +1528% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $390K Jan 1, 2017 Dec 31, 2017 10-K 2019-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.